Free Trial

Ardelyx (ARDX) News Today

→ It's time to ween off Chinese lithium! (From Smallcaps Daily) (Ad)
Free ARDX Stock Alerts
$6.45
-0.29 (-4.30%)
(As of 06/7/2024 08:51 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends
June 9 at 11:55 AM | marketbeat.com
Rubric Capital Management LP Purchases 1,512,753 Shares of Ardelyx, Inc. (NASDAQ:ARDX)
Rubric Capital Management LP increased its position in shares of Ardelyx, Inc. (NASDAQ:ARDX - Free Report) by 60.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 4,012,753 shares of the biopharmaceutical company's stock
June 9 at 5:54 AM | americanbankingnews.com
Insider Selling: Ardelyx, Inc. (NASDAQ:ARDX) Insider Sells 145,000 Shares of Stock
June 8 at 8:30 AM | insidertrades.com
Ardelyx, Inc. (NASDAQ:ARDX) Insider Sells $1,032,400.00 in Stock
June 8 at 1:30 AM | americanbankingnews.com
Ardelyx (NASDAQ:ARDX) Shares Down 5.5% After Insider Selling
June 7 at 5:52 AM | americanbankingnews.com
David P. Rosenbaum Sells 17,872 Shares of Ardelyx, Inc. (NASDAQ:ARDX) Stock
June 7 at 5:14 AM | americanbankingnews.com
Ardelyx (NASDAQ:ARDX) Upgraded at StockNews.com
June 6, 2024 | marketbeat.com
Ardelyx (NASDAQ:ARDX) Upgraded by StockNews.com to "Hold"
StockNews.com upgraded shares of Ardelyx from a "sell" rating to a "hold" rating in a research report on Thursday.
June 6, 2024 | marketbeat.com
Ardelyx (NASDAQ:ARDX) Trading Down 5.5% on Insider Selling
Ardelyx (NASDAQ:ARDX) Trading Down 5.5% Following Insider Selling
June 6, 2024 | insidertrades.com
Insider Selling: Ardelyx, Inc. (NASDAQ:ARDX) Insider Sells 17,872 Shares of Stock
June 6, 2024 | marketbeat.com
Rafferty Asset Management LLC Has $8.53 Million Stock Holdings in Ardelyx, Inc. (NASDAQ:ARDX)
Rafferty Asset Management LLC grew its holdings in shares of Ardelyx, Inc. (NASDAQ:ARDX - Free Report) by 25.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,375,514 shares of the biopharmaceutical com
June 4, 2024 | americanbankingnews.com
Ardelyx, Inc. (NASDAQ:ARDX) Short Interest Update
June 3, 2024 | americanbankingnews.com
Ardelyx, Inc. (NASDAQ:ARDX) CEO Sells $50,400.00 in Stock
June 2, 2024 | marketbeat.com
Ardelyx, Inc. (NASDAQ:ARDX) Short Interest Down 6.1% in May
Ardelyx, Inc. (NASDAQ:ARDX - Get Free Report) was the target of a large decline in short interest during the month of May. As of May 15th, there was short interest totalling 33,040,000 shares, a decline of 6.1% from the April 30th total of 35,170,000 shares. Based on an average daily volume of 5,610,000 shares, the days-to-cover ratio is presently 5.9 days.
June 1, 2024 | insidertrades.com
Insider Selling: Ardelyx, Inc. (NASDAQ:ARDX) CEO Sells 7,500 Shares of Stock
May 31, 2024 | americanbankingnews.com
Analyzing Landos Biopharma (NASDAQ:LABP) and Ardelyx (NASDAQ:ARDX)
May 30, 2024 | globenewswire.com
Ardelyx, Inc. Reports Employment Inducement Grants
May 30, 2024 | investorplace.com
Medical Moonshots: 3 Biotech Stocks Set to Skyrocket
May 30, 2024 | marketbeat.com
Charles Schwab Investment Management Inc. Acquires 150,465 Shares of Ardelyx, Inc. (NASDAQ:ARDX)
Charles Schwab Investment Management Inc. boosted its holdings in Ardelyx, Inc. (NASDAQ:ARDX - Free Report) by 9.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 1,816,732 shares of the biopharmaceutical company's
May 26, 2024 | marketbeat.com
Ardelyx, Inc. (NASDAQ:ARDX) Receives Average Rating of "Buy" from Analysts
Shares of Ardelyx, Inc. (NASDAQ:ARDX - Get Free Report) have been assigned a consensus rating of "Buy" from the nine research firms that are presently covering the company, Marketbeat.com reports. Eight equities research analysts have rated the stock with a buy recommendation and one has issued a
May 24, 2024 | msn.com
Ardelyx slips as commercial chief departs
May 24, 2024 | marketbeat.com
Ardelyx's (ARDX) "Overweight" Rating Reaffirmed at Piper Sandler
Piper Sandler reiterated an "overweight" rating and issued a $15.00 target price on shares of Ardelyx in a research note on Friday.
May 24, 2024 | marketbeat.com
Ardelyx (NASDAQ:ARDX) Trading Down 3.6%
Ardelyx (NASDAQ:ARDX) Trading Down 3.6%
May 22, 2024 | benzinga.com
Latest News for Ardelyx Stock (NASDAQ:ARDX)
May 22, 2024 | globenewswire.com
Ardelyx to Participate at the 2024 Jefferies Global Healthcare Conference
May 22, 2024 | marketbeat.com
BNP Paribas Financial Markets Acquires 393,801 Shares of Ardelyx, Inc. (NASDAQ:ARDX)
BNP Paribas Financial Markets grew its holdings in Ardelyx, Inc. (NASDAQ:ARDX - Free Report) by 156.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 644,975 shares of the biopharmaceutical company's stock
May 21, 2024 | globenewswire.com
Ardelyx Presents Additional Data at the 2024 Digestive Disease Week Conference on IBSRELA® (tenapanor), a First-In-Class Treatment for IBS-C in Adults
May 19, 2024 | investorplace.com
The 3 Best Penny Stocks to Buy in May 2024
May 17, 2024 | marketbeat.com
Russell Investments Group Ltd. Acquires 267,183 Shares of Ardelyx, Inc. (NASDAQ:ARDX)
Russell Investments Group Ltd. grew its stake in Ardelyx, Inc. (NASDAQ:ARDX - Free Report) by 392,916.2% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 267,251 shares of the biopharmaceutic
May 16, 2024 | insidertrades.com
Insider Selling: Ardelyx, Inc. (NASDAQ:ARDX) CEO Sells 3,000 Shares of Stock
May 16, 2024 | globenewswire.com
Ardelyx Presents Additional Data at the NKF 2024 Spring Clinical Meetings on XPHOZAH® (tenapanor)
May 15, 2024 | msn.com
Ardelyx (NASDAQ:ARDX): A Commercial-Stage Biopharma Stock with Growth Potential
May 14, 2024 | marketbeat.com
Ardelyx (NASDAQ:ARDX) Shares Down 3.7%
Ardelyx (NASDAQ:ARDX) Trading Down 3.7%
May 14, 2024 | globenewswire.com
Ardelyx, Inc. Reports Employment Inducement Grants
May 10, 2024 | seekingalpha.com
Ardelyx: Strong Execution, Fairly Valued
May 10, 2024 | insidertrades.com
Ardelyx, Inc. (NASDAQ:ARDX) Insider Sells $1,832,374.28 in Stock
May 9, 2024 | marketbeat.com
Insider Selling: Ardelyx, Inc. (NASDAQ:ARDX) Insider Sells 207,988 Shares of Stock
Ardelyx, Inc. (NASDAQ:ARDX - Get Free Report) insider Robert Ora Felsch sold 207,988 shares of Ardelyx stock in a transaction dated Monday, May 6th. The stock was sold at an average price of $8.81, for a total transaction of $1,832,374.28. Following the transaction, the insider now owns 95,947 shares of the company's stock, valued at approximately $845,293.07. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.
May 8, 2024 | marketbeat.com
Ardelyx (NASDAQ:ARDX) Stock Price Down 8.1% on Insider Selling
Ardelyx (NASDAQ:ARDX) Shares Down 8.1% Following Insider Selling
May 8, 2024 | insidertrades.com
Laura A. Williams Sells 39,949 Shares of Ardelyx, Inc. (NASDAQ:ARDX) Stock
May 7, 2024 | globenewswire.com
Ardelyx to Present Additional Data Supporting First-In-Class IBSRELA® (tenapanor) for Adults with Irritable Bowel Syndrome with Constipation at the 2024 Digestive Disease Week Conference
May 4, 2024 | finance.yahoo.com
Ardelyx First Quarter 2024 Earnings: Beats Expectations
May 4, 2024 | finance.yahoo.com
Ardelyx, Inc. (NASDAQ:ARDX) Q1 2024 Earnings Call Transcript
May 3, 2024 | marketbeat.com
Ardelyx (NASDAQ:ARDX) Announces Quarterly Earnings Results
Ardelyx (NASDAQ:ARDX - Get Free Report) issued its quarterly earnings data on Thursday. The biopharmaceutical company reported ($0.11) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.13) by $0.02. The company had revenue of $46.00 million during the quarter, compared to the consensus estimate of $36.40 million. Ardelyx had a negative net margin of 53.08% and a negative return on equity of 43.57%. The firm's revenue was up 303.5% compared to the same quarter last year. During the same quarter in the prior year, the firm earned ($0.13) earnings per share.
May 3, 2024 | marketbeat.com
Ardelyx (NASDAQ:ARDX) Shares Gap Up Following Strong Earnings
Ardelyx (NASDAQ:ARDX) Shares Gap Up Following Strong Earnings
May 3, 2024 | marketbeat.com
Stock Traders Buy High Volume of Call Options on Ardelyx (NASDAQ:ARDX)
Ardelyx, Inc. (NASDAQ:ARDX - Get Free Report) saw unusually large options trading on Friday. Stock investors acquired 18,613 call options on the company. This is an increase of approximately 219% compared to the typical daily volume of 5,838 call options.
May 3, 2024 | seekingalpha.com
Ardelyx Stock: A Crowded Market Curbs The Enthusiasm (Rating Downgrade)
May 3, 2024 | marketwatch.com
Ardelyx Shares Rally Premarket as 1Q Revenue Tops Street Views
May 2, 2024 | investorplace.com
ARDX Stock Earnings: Ardelyx Beats EPS, Beats Revenue for Q1 2024
May 2, 2024 | sfgate.com
Ardelyx: Q1 Earnings Snapshot
May 2, 2024 | globenewswire.com
Ardelyx Reports First Quarter 2024 Financial Results and Provides Business Update
May 2, 2024 | insidertrades.com
Insider Selling: Ardelyx, Inc. (NASDAQ:ARDX) CEO Sells 30,000 Shares of Stock
Get Ardelyx News Delivered to You Automatically

Sign up to receive the latest news and ratings for ARDX and its competitors with MarketBeat's FREE daily newsletter.

It's time to ween off Chinese lithium! (Ad)

As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promising companies to be watching closely

Learn how this American company is leading the lithium-ion revolution

ARDX Media Mentions By Week

ARDX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ARDX
News Sentiment
▼
0.71

0.76
▲
Average
Medical
News Sentiment

ARDX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ARDX Articles
This Week
▼
14

5
▲
ARDX Articles
Average Week

Get Ardelyx News Delivered to You Automatically

Sign up to receive the latest news and ratings for ARDX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:ARDX) was last updated on 6/10/2024 by MarketBeat.com Staff

From Our Partners
Write this ticker symbol down…
A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...
StocksToTrade | Sponsored
It's time to ween off Chinese lithium!
As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...
Smallcaps Daily | Sponsored
Top 5 Tech Stocks to Buy for 2024
The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...
Daily Market Alerts | Sponsored
Top 5 AI Stocks to Buy for 2024
The electric vehicle boom is accelerating – and fast.
Market Moving Trends | Sponsored
No Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for Free
Optimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...
Hedgeye | Sponsored
The Only Energy Play You Should Be Looking At
Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...
Wealthpin Pro | Sponsored
RSVP: Charles Payne’s Cash Flow Workshop
Did you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...
Unstoppable Prosperity | Sponsored
Buy this small stock before coming AI Tidal Wave
The internet generated more wealth than any other innovation in history - creating hundreds of thousands of ne...
Chaikin Analytics | Sponsored